Psoriasis Following Bariatric Surgery: Clinical Evolution and Impact on Quality of Life on 10 patients
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Psoriasis is a chronic systemic disease with important skin manifestations, affecting 2 % of the population. It is more frequent and severe in obese patients, and both have been associated with a higher cardiovascular risk. Recent studies suggest that weight loss may improve psoriasis and metabolic comorbidities in obese patients. We reviewed our prospective electronic database for all patients with psoriasis who underwent bariatric surgery between 2008 and 2011. We assessed surgical complications, weight progression, and psoriasis-related outcomes. The Dermatology Life Quality Index was used retrospectively to assess quality of life (QoL) before and after the operation. Ten patients were included; body mass index was 38.8 ± 5.2 kg/m2. Pre-surgical treatment for psoriasis was topical (50 %) and systemic (40 %). Eight patients underwent laparoscopic Roux-en-Y gastric bypass and two underwent laparoscopic sleeve gastrectomy. At follow-up, the mean percent excess weight loss 1, 6, and 12 months after surgery was 45 %, 80 %, and 88 %, respectively. Comorbidity resolution was 75 % for diabetes mellitus, 100 % for insulin resistance, and 57 % for hypertension. Related to psoriasis, 70 % of the patients stayed in remission 6 months after surgery and three of the four patients who were previously medicated with systemic drugs discontinued medication. The impact of psoriasis on QoL improved from 14.9 ± 6.8 before surgery to 5 ± 6.3 after surgery (p = 0.005). Bariatric surgery for positive metabolic, skin, and quality of life results should be considered as a useful adjuvant therapy for obese patients with psoriasis.
- Schön MP, Boehncke WH. Psoriasis. N Engl J Med. 2005;352:1899–912. CrossRef
- Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210–6. CrossRef
- Gelfand JM, Neimann AL, Shin DB, et al. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006;296:1735–41. CrossRef
- Farias MM, Cuevas AM, Rodriguez F. Set-point theory and obesity. Metab Syndr Relat Disord. 2011;9:85–9. CrossRef
- Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37. CrossRef
- Perry CD, Hutter MM, Smith DB, et al. Survival and changes in comorbidities after bariatric surgery. Ann Surg. 2008;247:21–7. CrossRef
- Bardazzi F, Balestri R, Baldi E, et al. Correlation between BMI and PASI in patients affected by moderate to severe psoriasis undergoing biological therapy. Dermatol Ther. 2010;23:S14–9. CrossRef
- Higa-Sansone G, Szomstein S, Soto F, et al. Psoriasis remission after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Obes Surg. 2004;14:1132–4. CrossRef
- de Menezes Ettinger JE, Azaro E, de Souza CA, et al. Remission of psoriasis after open gastric bypass. Obes Surg. 2006;16:94–7. CrossRef
- Duarte GV, Follador I, Cavalheiro CM, et al. Psoriasis and obesity: literature review and recommendations for management. An Bras Dermatol. 2010;85:355–60. CrossRef
- Gisondi P, Del Giglio M, Di Francesco V, et al. Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial. Am J Clin Nutr. 2008;88:1242–7.
- Hossler E, Marron M, Moward C. Gastric bypass surgery improves psoriasis. Am Acta Dermatol 2010. [Epub ahead of print].
- Pérez-Pérez L, Allegue F, Caeiro JL, et al. Severe psoriasis, morbid obesity and bariatric surgery. Clin Exp Dermatol. 2009;34:421–2. CrossRef
- Basra MK, Fenech R, Gatt RM, et al. The Dermatology Life Quality Index 1994–2007: a comprehensive review of validation data and clinical results. Br J Dermatol. 2008;159:997–1035.
- Neimann AL, Shin DB, Wang X, et al. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol. 2006;55:829–35. CrossRef
- Kaye JA, Li L, Jick SS. Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis. Br J Dermatol. 2008;159:895–902. CrossRef
- Kern PA, Saghizadeh M, Ong JM, et al. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest. 1995;95:2111–9. CrossRef
- Choi WJ, Park EJ, Kwon IH, et al. Association between psoriasis and cardiovascular risk factors in Korean patients. Ann Dermatol. 2010;22:300–6. CrossRef
- Mease PJ. Psoriatic arthritis, update on pathophysiology, assessment and management. Bull NYU Hosp Joint Dis. 2010;68(3):191–8.
- Rapp SR, Feldman SR, Exum ML, et al. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999;41:401–7. CrossRef
- Psoriasis Following Bariatric Surgery: Clinical Evolution and Impact on Quality of Life on 10 patients
Volume 22, Issue 6 , pp 877-880
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Bariatric surgery
- Quality of life
- Weight loss
- Industry Sectors
- Author Affiliations
- 1. Master in Nutrition Program, Pontificia Universidad Católica de Chile, Albacete 4420, Dep. 56, Las Condes, Santiago, Chile
- 2. Department of Surgery, Pontificia Universidad Católica de Chile, Santiago, Chile
- 3. Department of Digestive Surgery, Pontificia Universidad Católica de Chile, Santiago, Chile
- 4. Department of Dermatology, Pontificia Universidad Católica de Chile, Santiago, Chile